Showing results (141-150 of 6,269) with videos related to

Sort By:
Pageof 627
Diabetes, Obesity & Metabolism|August 8, 2018
Efficacy and safety of fixed-dose combination therapy with gemigliptin (50 mg) and rosuvastatin compared with monotherapy in patients with type 2 diabetes and dyslipidaemia (BALANCE): A multicentre, randomized, double-blind, controlled, phase 3 trialJi Cheol Bae, Kyung Wan Min, Yong Hyun Kim, et al.
Diabetes, Obesity & Metabolism|September 15, 2017
Efficacy and safety of alirocumab in insulin-treated individuals with type 1 or type 2 diabetes and high cardiovascular risk: The ODYSSEY DM-INSULIN randomized trialLawrence A Leiter, Bertrand Cariou, Dirk Müller-Wieland, et al.
Diabetes, Obesity & Metabolism|January 28, 2020
Efficacy and tolerability of tirzepatide, a dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist in patients with type 2 diabetes: A 12-week, randomized, double-blind, placebo-controlled study to evaluate different dose-escalation regimensJuan Pablo Frias, Michael A Nauck, Joanna Van, et al.
Diabetes, Obesity & Metabolism|January 28, 2020
Gluten-free diet in children with recent-onset type 1 diabetes: A 12-month intervention trialVit Neuman, Stepanka Pruhova, Michal Kulich, et al.
Diabetes, Obesity & Metabolism|October 7, 2016
Addition of a dipeptidyl peptidase-4 inhibitor, sitagliptin, to ongoing therapy with the glucagon-like peptide-1 receptor agonist liraglutide: A randomized controlled trial in patients with type 2 diabetesMichael A Nauck, Melanie Kahle, Oleg Baranov, et al.
Diabetes, Obesity & Metabolism|August 16, 2019
Association between individual cholesterol and proteinuria response and exposure to atorvastatin or rosuvastatinMarjolein Y A M Kroonen, Jasper Stevens, Dick de Zeeuw, et al.
Diabetes, Obesity & Metabolism|October 3, 2019
Risk of first stroke in people with type 2 diabetes and its relation to glycaemic control: A nationwide observational studyAlexander Zabala, Vladimer Darsalia, Martin J Holzmann, et al.
Diabetes, Obesity & Metabolism|March 2, 2019
Clinical pharmacology study of ipragliflozin in Japanese patients with type 1 diabetes mellitus: A phase 2, randomized, placebo-controlled trialKohei Kaku, Hiroyuki Isaka, Junko Toyoshima, et al.
Diabetes, Obesity & Metabolism|March 10, 2019
Take Control: A randomized trial evaluating the efficacy and safety of self- versus physician-managed titration of insulin glargine 300 U/mL in patients with uncontrolled type 2 diabetesDavid Russell-Jones, Arnaud Dauchy, Elías Delgado, et al.
Diabetes, Obesity & Metabolism|February 21, 2019
Fixed-ratio combination of insulin degludec and liraglutide (IDegLira) improves cardiovascular risk markers in patients with type 2 diabetes uncontrolled on basal insulinTina Vilsbøll, Thomas C Blevins, Esteban Jodar, et al.
Pageof 627